Award
NIH Reporter #1P50HD123281-01
Project 1: Testing of KyA84, a Potential Male Contraceptive, in Man
Recipient
University of Washington
Award Amount
$134,860.00
Ceiling
$134,860.00
Awarded
September 04, 2026
Identifier
1P50HD123281-01
This award funds research on KyA84, a potential oral and reversible male contraceptive, including first-in-human studies to develop a safe and effective male contraceptive.
Description
Testing of KyA84, a Potential Male Contraceptive, in Man (Project I). The goal of our center is the development of novel male contraceptives that reversibly suppress sperm production in men. We have identified a drug, KyA84, that inhibits sperm production in minipigs. In this proposal, we will perform first-in-human studies of KyA83, which, when completed, will result in substantial progress towards the development of a safe and effective, oral, reversible contraceptive for men.